Gastroenterology
Volume 138, Issue 3 , Pages 1143-1154.e2, March 2010

Loss or Silencing of the PHD1 Prolyl Hydroxylase Protects Livers of Mice Against Ischemia/Reperfusion Injury

  • Martin Schneider

      Affiliations

    • Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Germany
  • ,
  • Katie Van Geyte

      Affiliations

    • Vesalius Research Center, K.U. Leuven, Leuven, Belgium
    • Vesalius Research Center, VIB, Leuven, Belgium
  • ,
  • Peter Fraisl

      Affiliations

    • Vesalius Research Center, K.U. Leuven, Leuven, Belgium
    • Vesalius Research Center, VIB, Leuven, Belgium
  • ,
  • Judit Kiss

      Affiliations

    • Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Germany
  • ,
  • Julián Aragonés

      Affiliations

    • Vesalius Research Center, K.U. Leuven, Leuven, Belgium
    • Vesalius Research Center, VIB, Leuven, Belgium
    • Immunology Department, Hospital de la Princess-UAM, Madrid, Spain
  • ,
  • Massimiliano Mazzone

      Affiliations

    • Vesalius Research Center, K.U. Leuven, Leuven, Belgium
    • Vesalius Research Center, VIB, Leuven, Belgium
  • ,
  • Heimo Mairbäurl

      Affiliations

    • Medical Clinic VII, Sports Medicine, University of Heidelberg, Germany
  • ,
  • Katrien De Bock

      Affiliations

    • Vesalius Research Center, K.U. Leuven, Leuven, Belgium
    • Vesalius Research Center, VIB, Leuven, Belgium
  • ,
  • Nam Ho Jeoung

      Affiliations

    • Department of Biochemistry and Molecular Biology, Indiana School of Medicine, Indianapolis, Indiana
  • ,
  • Martin Mollenhauer

      Affiliations

    • Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Germany
  • ,
  • Maria Georgiadou

      Affiliations

    • Vesalius Research Center, K.U. Leuven, Leuven, Belgium
    • Vesalius Research Center, VIB, Leuven, Belgium
  • ,
  • Tammie Bishop

      Affiliations

    • Henry Wellcome Building of Molecular Physiology, Oxford, UK
  • ,
  • Carmen Roncal

      Affiliations

    • Vesalius Research Center, K.U. Leuven, Leuven, Belgium
    • Vesalius Research Center, VIB, Leuven, Belgium
  • ,
  • Andrew Sutherland

      Affiliations

    • Henry Wellcome Building of Molecular Physiology, Oxford, UK
  • ,
  • Benedicte Jordan

      Affiliations

    • Biomedical MRI Unit, U.C. Louvain, Louvain, Belgium
  • ,
  • Bernard Gallez

      Affiliations

    • Biomedical MRI Unit, U.C. Louvain, Louvain, Belgium
  • ,
  • Jürgen Weitz

      Affiliations

    • Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Germany
  • ,
  • Robert A. Harris

      Affiliations

    • Department of Biochemistry and Molecular Biology, Indiana School of Medicine, Indianapolis, Indiana
  • ,
  • Patrick Maxwell

      Affiliations

    • Imperial College London, London, UK
  • ,
  • Myriam Baes

      Affiliations

    • Laboratory of Cell Metabolism, K.U. Leuven, Leuven, Belgium
  • ,
  • Peter Ratcliffe

      Affiliations

    • Henry Wellcome Building of Molecular Physiology, Oxford, UK
  • ,
  • Peter Carmeliet

      Affiliations

    • Vesalius Research Center, K.U. Leuven, Leuven, Belgium
    • Vesalius Research Center, VIB, Leuven, Belgium
    • Corresponding Author InformationReprint requests Address requests for reprints to: P. Carmeliet, MD, PhD, Vesalius Research Center (VRC), VIB, K. U. Leuven, Campus Gasthuisberg, Herestraat 49, B-3000, Leuven, Belgium. fax: (32) 16 34 59 90

Received 2 May 2009; accepted 25 September 2009. published online 09 October 2009.

Background & Aims

Liver ischemia/reperfusion (I/R) injury is a frequent cause of organ dysfunction. Loss of the oxygen sensor prolyl hydroxylase domain enzyme 1 (PHD1) causes tolerance of skeletal muscle to hypoxia. We assessed whether loss or short-term silencing of PHD1 could likewise induce hypoxia tolerance in hepatocytes and protect them against hepatic I/R damage.

Methods

Hepatic ischemia was induced in mice by clamping of the portal vessels of the left lateral liver lobe; 90 minutes later livers were reperfused for 8 hours for I/R experiments. Hepatocyte damage following ischemia or I/R was investigated in PHD1-deficient (PHD1−/−) and wild-type mice or following short hairpin RNA-mediated short-term inhibition of PHD1 in vivo.

Results

PHD1−/− livers were largely protected against acute ischemia or I/R injury. Among mice subjected to hepatic I/R followed by surgical resection of all nonischemic liver lobes, more than half of wild-type mice succumbed, whereas all PHD1−/− mice survived. Also, short-term inhibition of PHD1 through RNA interference−mediated silencing provided protection against I/R. Knockdown of PHD1 also induced hypoxia tolerance of hepatocytes in vitro. Mechanistically, loss of PHD1 decreased production of oxidative stress, which likely relates to a decrease in oxygen consumption as a result of a reprogramming of hepatocellular metabolism.

Conclusions

Loss of PHD1 provided tolerance of hepatocytes to acute hypoxia and protected them against I/R-damage. Short-term inhibition of PHD1 is a novel therapeutic approach to reducing or preventing I/R-induced liver injury.

Keywords: PHD1, Prolyl Hydroxylase, Ischemia/Reperfusion

Abbreviations used in this paper: ALT, alanine aminotransferase, HIF, hypoxia inducible factor, I/R, ischemia/reperfusion, 8-OHdG, 8-hydroxy-2′-deoxyguanosine, PDC, pyruvate dehydrogenase enzyme complex, PDK, pyruvate dehydrogenase kinase, PHD, prolyl hydroxylase domain, ROS, reactive oxygen species, WT, wild-type

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Conflicts of interest The authors disclose the following: P.R. and P.M. are scientific co-founders of ReOx Ltd, a University spin-out company that seeks to develop HIF Hydroxylase Inhibitors. The remaining authors disclose no conflicts.

 Funding Supported by the Emmy Noether-Program of the Deutsche Forschungsgemeinschaft (to MS), by grant IUAP06/30 from the Federal Government Belgium, and by grants FWO G.0265 and FWO G.0387 from the Flanders Research Foundation, Belgium.

PII: S0016-5085(09)01752-1

doi:10.1053/j.gastro.2009.09.057

Gastroenterology
Volume 138, Issue 3 , Pages 1143-1154.e2, March 2010